Understanding ICH E6 (R3): Good Clinical Practice and Computerised Systems Validation

REPHINE SPEECH MARKS OPEN DIGITALISATION

In the era of digital trials, ensuring data integrity isn’t optional — it’s essential. ICH E6 (R3) redefines compliance for computerised systems — are you ready?

REPHINE SPEECH MARKS CLOSE DIGITALISATION

About this Guide

Stay ahead of GCP regulatory changes with our ICH E6 (R3) guide — designed for clinical trial sponsors, CROs, and validation experts.

The ICH E6 (R3) guideline introduces critical updates to Good Clinical Practice (GCP), focusing on computerised systems validation, data integrity, and risk-based system management. Published on January 6, 2025, and set for EMA adoption from July 23, 2025, this revision ensures clinical trials align with modern technology and regulatory compliance requirements.

Our expert guide breaks down the essential ICH E6 (R3) updates, including:

Enhanced computerised systems requirements, with a dedicated chapter on system validation, user responsibilities, and operational controls.

Risk-based computer system validation (CSV) approaches to ensure compliance while improving efficiency and data reliability.

Advanced data integrity measures, covering audit trails, user authentication, cybersecurity, and disaster recovery planning.

New system deployment guidelines, detailing approval processes, contingency planning, and user training for GCP compliance.

For a deeper dive into AIQSV, download the guide now.

Hero Image ICH E6 Guide

🔍Why download this Guide?

This guide empowers your team to:

📌 Understand key changes in computerised system validation and data integrity requirements.

📌 Ensure GCP compliance and avoid regulatory setbacks.

📌 Implement risk-based validation strategies to streamline system qualification and deployment.

📌 Prepare your organisation for evolving GCP regulations and ICH E6 (R3) standards.

Who is this guide for?

This guide is essential for professionals working with clinical trial systems and validation, including:

🔹 Clinical trial sponsors and CROs

🔹 Regulatory affairs teams

🔹 IT specialists and system validation experts

🔹 Quality and compliance professionals

Ensure your clinical trials meet the latest ICH E6 (R3) standards with expert guidance on computerised systems validation.

View our other resources and company news

Dmf case study header Case Study

Navigating DMF Registration in China with Rephine

Explore case study showing the development of a project for a new pharmaceutical manufacturing plant with the objective to fulfill GMP requirements and minimise risks ...
Read More
DMF blog image mar 25 Blog

Breaking into the Chinese Pharmaceutical Market: How to Successfully File a DMF

Learn how to navigate DMF submission in China with Rephine’s expert guidance. From compliance reviews to NMPA approval — streamline your entry into the Chinese ...
Read More
ICH E6 Guide Header Image (1500 x 844 px) CSV

Understanding ICH E6 (R3): Good Clinical Practice and Computerised Systems Validation

The Guide for an Integrated Lifecycle Approach to Analytical Instrument Qualification and System Validation (AIQSV) is an essential resource for pharmaceutical laboratories striving to meet ...
Read More
Intended Purpose MedTech Guide Header Image (1500 x 844 px) Guide

Understanding Intended Purpose in EU MDR & IVDR: Key Implications for Medical Device Manufacturers

Our guide simplifies GSPR compliance, helping medical device companies meet EU safety standards, streamline CE marking, and get market-ready faster.
Read More
qms background Guide

Why eQMS is Important? The Critical Role of eQMS in Modern Quality Management

Navigating the intricate landscape of implementing systems in Life Sciences Quality & R&D requires a strategic approach to the end-to-end
Read More
UKCA Marking Header image Guide

Understanding the UKCA Certification for Medical Devices

Navigating UKCA certification is essential for manufacturers seeking access to the Great Britain market. Understanding the regulatory landscape, transitional provisions, and compliance steps is key ...
Read More
Key Deadlines Header image Ebook

Key Deadlines for Medical Device Manufacturers under MDR and IVDR

Discover everything you need to know about MDR and IVDR compliance timelines for 2025. This eBook provides actionable insights to help manufacturers stay compliant and ...
Read More
rems audits Guide

REMS Program Audits: Ensuring Safety and Compliance

Navigating the FDA’s Risk Evaluation and Mitigation Strategy (REMS) requirements can be challenging, but it is critical for ensuring medication safety and regulatory compliance.
Read More
AI CSV Jan 2025 blog Blog

Considerations for the Use of Artificial Intelligence in Regulatory Decision-Making for Drugs and Biological Products

In January 2025, the FDA issued a draft guidance to industry and stakeholders on the use of artificial intelligence (AI) to generate information or data ...
Read More
Contact Us